Boxer Capital, LLC
- SEC CIK
- 0001465837
- Latest filing
- Feb 14, 2025
Holdings in Q3 2024
Holdings as of Sep 30, 2024, filed Nov 14, 2024. Long positions only; changes compare share counts with Q2 2024.
- Positions
- 68
- +7 vs. Q2 2024
- Portfolio value
- $2.04B
- +$138.9M (+7.3%) vs. Q2 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| RVMDRevolution Medicines, Inc. | COM | 4,279,464 | $194.1M | 9.5% | 00.0% | Unchanged | History |
| TYRATyra Biosciences, Inc. | COM | 6,448,359 | $151.6M | 7.4% | 00.0% | Unchanged | History |
| NUVLNuvalent, Inc. | COM | 1,120,192 | $114.6M | 5.6% | 00.0% | Unchanged | History |
| ONCBeOne Medicines Ltd. | ADR | 500,000 | $112.3M | 5.5% | 00.0% | Unchanged | History |
| CYTKCytokinetics Inc | COM NEW | 2,100,000 | $110.9M | 5.4% | 00.0% | Unchanged | History |
| SWTXSpringWorks Therapeutics, Inc. | COM | 3,421,541 | $109.6M | 5.4% | 00.0% | Unchanged | History |
| MRUSMerus N.V. | COM | 1,900,000 | $94.9M | 4.7% | 00.0% | Unchanged | History |
| SRPTSarepta Therapeutics, Inc. | COM | 650,000 | $81.2M | 4.0% | 00.0% | Unchanged | History |
| Avidity Biosciences, Inc.05370A108 | COM | 1,727,388 | $79.3M | 3.9% | 00.0% | Unchanged | – |
| IDYAIDEAYA Biosciences, Inc. | COM | 2,202,812 | $69.8M | 3.4% | 00.0% | Unchanged | History |
| TNGXTango Therapeutics, Inc. | COM | 8,198,642 | $63.1M | 3.1% | 00.0% | Unchanged | History |
| ARGXArgenx SE | SPONSORED ADR | 100,000 | $54.2M | 2.7% | 00.0% | Unchanged | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 1,726,000 | $49.8M | 2.4% | 00.0% | Unchanged | History |
| AKROAkero Therapeutics, Inc. | COM | 1,676,733 | $48.1M | 2.4% | 00.0% | Unchanged | History |
| ANABAnaptysbio, Inc | COM | 1,300,000 | $43.5M | 2.1% | 00.0% | Unchanged | History |
| AXSMAxsome Therapeutics, Inc. | COM | 400,000 | $35.9M | 1.8% | 00.0% | Unchanged | History |
| ITOSiTeos Therapeutics, Inc. | COM | 2,946,915 | $30.1M | 1.5% | 00.0% | Unchanged | History |
| LEGNLegend Biotech Corp | SPONSORED ADS | 600,000 | $29.2M | 1.4% | 00.0% | Unchanged | History |
| GERNGeron Corp | COM | 6,000,000 | $27.2M | 1.3% | 00.0% | Unchanged | History |
| THRDThird Harmonic Bio, Inc. | COM | 2,000,000 | $27.1M | 1.3% | 00.0% | Unchanged | History |
| RCKTRocket Pharmaceuticals, Inc. | COM | 1,466,051 | $27.1M | 1.3% | 00.0% | Unchanged | History |
| RCUSArcus Biosciences, Inc. | COM | 1,602,200 | $24.5M | 1.2% | 00.0% | Unchanged | History |
| TILInstil Bio, Inc. | COM NEW | 355,500 | $23.9M | 1.2% | +355,500 | New | History |
| XENEXenon Pharmaceuticals Inc. | COM | 600,000 | $23.6M | 1.2% | 00.0% | Unchanged | History |
| IMVTImmunovant, Inc. | COM | 825,000 | $23.5M | 1.2% | 00.0% | Unchanged | History |
| KYMRKymera Therapeutics, Inc. | COM | 450,000 | $21.3M | 1.0% | +450,000 | New | History |
| SYRESpyre Therapeutics, Inc. | COM NEW | 696,480 | $20.5M | 1.0% | 00.0% | Unchanged | History |
| KURAKura Oncology, Inc. | COM | 1,000,000 | $19.5M | 1.0% | 00.0% | Unchanged | History |
| KALVKalVista Pharmaceuticals, Inc. | COM | 1,590,000 | $18.4M | 0.9% | 00.0% | Unchanged | History |
| NKTXNkarta, Inc. | COM | 4,029,606 | $18.2M | 0.9% | −1,577,744−28.1% | Reduced | History |
| ORICOric Pharmaceuticals, Inc. | COM | 1,732,571 | $17.8M | 0.9% | 00.0% | Unchanged | History |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 400,000 | $17.6M | 0.9% | 00.0% | Unchanged | History |
| FATEFate Therapeutics Inc | COM | 4,960,910 | $17.4M | 0.9% | −3,255,000−39.6% | Reduced | History |
| ELVNEnliven Therapeutics, Inc. | COM | 671,358 | $17.1M | 0.8% | 00.0% | Unchanged | History |
| REPLReplimune Group, Inc. | COM | 1,536,341 | $16.8M | 0.8% | 00.0% | Unchanged | History |
| DAWNDay One Biopharmaceuticals, Inc. | Stock | 1,189,943 | $16.6M | 0.8% | 00.0% | Unchanged | History |
| CGEMCullinan Therapeutics, Inc. | COM | 907,895 | $15.2M | 0.7% | +250,000+38.0% | Added | History |
| ARVNArvinas, Inc. | COM | 608,614 | $15.0M | 0.7% | 00.0% | Unchanged | History |
| CLYMClimb Bio, Inc. | COM | 2,603,190 | $13.3M | 0.7% | 00.0% | Unchanged | History |
| RLAYRelay Therapeutics, Inc. | COM | 1,819,132 | $12.9M | 0.6% | 00.0% | Unchanged | History |
| NRIXNurix Therapeutics, Inc. | COM | 563,067 | $12.7M | 0.6% | +563,067 | New | History |
| PRTAProthena Corp Public Ltd Co | SHS | 690,000 | $11.5M | 0.6% | 00.0% | Unchanged | History |
| QUREuniQure N.V. | SHS | 2,225,000 | $11.0M | 0.5% | +2,225,000 | New | History |
| APGEApogee Therapeutics, Inc. | COM | 179,000 | $10.5M | 0.5% | +179,000 | New | History |
| OLMAOlema Pharmaceuticals, Inc. | COM | 650,000 | $7.76M | 0.4% | 00.0% | Unchanged | History |
| IOVAIovance Biotherapeutics, Inc. | COM | 750,000 | $7.04M | 0.3% | 00.0% | Unchanged | History |
| IPSCCentury Therapeutics, Inc. | COM | 3,900,000 | $6.67M | 0.3% | −1,001,603−20.4% | Reduced | History |
| JSPRJasper Therapeutics, Inc. | COM NEW | 350,000 | $6.58M | 0.3% | 00.0% | Unchanged | History |
| SANASana Biotechnology, Inc. | COM | 1,545,000 | $6.43M | 0.3% | 00.0% | Unchanged | History |
| TERNTerns Pharmaceuticals, Inc. | COM | 752,000 | $6.27M | 0.3% | +752,000 | New | History |
| SRRKScholar Rock Holding Corp | COM | 750,000 | $6.01M | 0.3% | +750,000 | New | History |
| PSTXPoseida Therapeutics, Inc. | COM | 2,000,000 | $5.72M | 0.3% | −2,475,000−55.3% | Reduced | History |
| SMMTSummit Therapeutics Inc. | COM | 250,000 | $5.47M | 0.3% | +250,000 | New | History |
| ENGNenGene Therapeutics Inc. | COM | 727,900 | $4.80M | 0.2% | 00.0% | Unchanged | History |
| PRLDPrelude Therapeutics Inc | COM | 1,708,187 | $3.54M | 0.2% | −860,100−33.5% | Reduced | History |
| BCAXBicara Therapeutics Inc. | COM | 135,000 | $3.44M | 0.2% | +135,000 | New | History |
| MRSNMersana Therapeutics, Inc. | COM | 1,817,000 | $3.43M | 0.2% | +1,817,000 | New | History |
| BOLDBoundless Bio, Inc. | COM | 711,329 | $2.47M | 0.1% | 00.0% | Unchanged | History |
| BDTXBlack Diamond Therapeutics, Inc. | COM | 506,000 | $2.20M | 0.1% | 00.0% | Unchanged | History |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 450,000 | $1.66M | 0.1% | 00.0% | Unchanged | History |
| TARAProtara Therapeutics, Inc. | COM STK | 811,627 | $1.49M | 0.1% | 00.0% | Unchanged | History |
| OBIOOrchestra BioMed Holdings, Inc. | COM | 238,193 | $1.22M | 0.1% | 00.0% | Unchanged | History |
| ZURAZura Bio Ltd | CLASS A ORD SHS | 300,000 | $1.22M | 0.1% | +300,000 | New | History |
| BCABBioAtla, Inc. | COM | 686,347 | $1.21M | 0.1% | 00.0% | Unchanged | History |
| MISTMilestone Pharmaceuticals Inc. | COM | 309,007 | $469.7K | <0.1% | 00.0% | Unchanged | History |
| DBVTDBV Technologies S.A. | SPONSORED ADR | 250,000 | $175.0K | <0.1% | +250,000 | New | History |
| Nuvation Bio Inc.67080N119 | *W EXP 07/07/202 | 266,666 | $26.1K | <0.1% | 00.0% | Unchanged | – |
| Surrozen, Inc.86889P117 | *W EXP 08/01/203 | 66,666 | $1.33K | <0.1% | 00.0% | Unchanged | – |
Sold out since Q2 2024 (5)
Positions held at the end of Q2 2024 that are gone from this filing.
| Security | Class | Shares in Q2 2024 | Value in Q2 2024 | % of portfolio in Q2 2024 | History |
|---|---|---|---|---|---|
| ALLOAllogene Therapeutics, Inc. | COM | 3,850,000 | $8.97M | 0.5% | History |
| AMLXAmylyx Pharmaceuticals, Inc. | COM | 1,500,000 | $2.85M | 0.2% | History |
| ABSIAbsci Corp | COM | 700,000 | $2.16M | 0.1% | History |
| ATRAAtara Biotherapeutics, Inc. | COM | 166,000 | $1.41M | 0.1% | History |
| DBVTDBV Technologies S.A. | SPONSORED ADR | 250,000 | $200.3K | <0.1% | History |